171 related articles for article (PubMed ID: 38056897)
1. CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.
Mao J; Li J; Chen J; Wen Q; Cao M; Zhang F; Li B; Zhang Q; Wang Z; Zhang J; Shen J
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056897
[TBL] [Abstract][Full Text] [Related]
2. Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model.
Mao J; Cao M; Zhang F; Zhang J; Duan X; Lu L; Yang Z; Zhang X; Zhu W; Zhang Q; Wang Z; Shen J
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169868
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
[TBL] [Abstract][Full Text] [Related]
4. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.
Liu CJ; Schaettler M; Blaha DT; Bowman-Kirigin JA; Kobayashi DK; Livingstone AJ; Bender D; Miller CA; Kranz DM; Johanns TM; Dunn GP
Neuro Oncol; 2020 Sep; 22(9):1276-1288. PubMed ID: 32133512
[TBL] [Abstract][Full Text] [Related]
5. Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma.
Mohme M; Maire CL; Geumann U; Schliffke S; Dührsen L; Fita K; Akyüz N; Binder M; Westphal M; Guenther C; Lamszus K; Hermann FG; Schmidt NO
Clin Cancer Res; 2020 Jun; 26(11):2626-2639. PubMed ID: 31988196
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model.
Park J; Park SA; Kim YS; Kim D; Shin S; Lee SH; Jeun SS; Chung YJ; Ahn S
Biomed Pharmacother; 2024 Apr; 173():115790. PubMed ID: 38431436
[TBL] [Abstract][Full Text] [Related]
7. Recruiting T-Cells toward the Brain for Enhanced Glioblastoma Immunotherapeutic Efficacy by Co-Delivery of Cytokines and Immune Checkpoint Antibodies with Macrophage-Membrane-Camouflaged Nanovesicles.
Xu X; Zhang Z; Du J; Xue Y; Chen X; Zhang J; Yang X; Chang D; Xie J; Ju S
Adv Mater; 2023 Jun; 35(25):e2209785. PubMed ID: 37101060
[TBL] [Abstract][Full Text] [Related]
8. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
[TBL] [Abstract][Full Text] [Related]
9. Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models.
Campian JL; Ghosh S; Kapoor V; Yan R; Thotala S; Jash A; Hu T; Mahadevan A; Rifai K; Page L; Lee BH; Ferrando-Martinez S; Wolfarth AA; Yang SH; Hallahan D; Chheda MG; Thotala D
Clin Cancer Res; 2022 Mar; 28(6):1229-1239. PubMed ID: 35031547
[TBL] [Abstract][Full Text] [Related]
10. Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.
Choi SH; Stuckey DW; Pignatta S; Reinshagen C; Khalsa JK; Roozendaal N; Martinez-Quintanilla J; Tamura K; Keles E; Shah K
Clin Cancer Res; 2017 Nov; 23(22):7047-7058. PubMed ID: 28912136
[No Abstract] [Full Text] [Related]
11. 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers.
Woroniecka KI; Rhodin KE; Dechant C; Cui X; Chongsathidkiet P; Wilkinson D; Waibl-Polania J; Sanchez-Perez L; Fecci PE
Clin Cancer Res; 2020 Mar; 26(6):1349-1358. PubMed ID: 31871298
[TBL] [Abstract][Full Text] [Related]
12. Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.
Zeng J; See AP; Phallen J; Jackson CM; Belcaid Z; Ruzevick J; Durham N; Meyer C; Harris TJ; Albesiano E; Pradilla G; Ford E; Wong J; Hammers HJ; Mathios D; Tyler B; Brem H; Tran PT; Pardoll D; Drake CG; Lim M
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):343-9. PubMed ID: 23462419
[TBL] [Abstract][Full Text] [Related]
13. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
14. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes.
Nishida M; Yamashita N; Ogawa T; Koseki K; Warabi E; Ohue T; Komatsu M; Matsushita H; Kakimi K; Kawakami E; Shiroguchi K; Udono H
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531248
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer.
Chen Y; Sun J; Luo Y; Liu J; Wang X; Feng R; Huang J; Du H; Li Q; Tan J; Ren G; Wang X; Li H
J Transl Med; 2022 Dec; 20(1):615. PubMed ID: 36564797
[TBL] [Abstract][Full Text] [Related]
17. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment
Park S; Oh JH; Park DJ; Zhang H; Noh M; Kim Y; Kim YS; Kim H; Kim YM; Ha SJ; Kwon YG
Front Immunol; 2020; 11():620166. PubMed ID: 33584714
[TBL] [Abstract][Full Text] [Related]
18. Combined Blockade of T Cell Immunoglobulin and Mucin Domain 3 and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Results in Durable Therapeutic Efficacy in Mice with Intracranial Gliomas.
Li J; Liu X; Duan Y; Liu Y; Wang H; Lian S; Zhuang G; Fan Y
Med Sci Monit; 2017 Jul; 23():3593-3602. PubMed ID: 28736431
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.
Akimoto K; Kimura K; Nagano M; Takano S; To'a Salazar G; Yamashita T; Ohneda O
Stem Cells Dev; 2013 May; 22(9):1370-86. PubMed ID: 23231075
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers.
Yang X; Zhao J; Duan S; Hou X; Li X; Hu Z; Tang Z; Mo F; Lu X
Theranostics; 2019; 9(14):4066-4083. PubMed ID: 31281532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
